LUVERIS Trademark

Trademark Overview

On Friday, January 21, 2022, a trademark application was filed for LUVERIS with the United States Patent and Trademark Office. The USPTO has given the LUVERIS trademark a serial number of 97232962. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Tuesday, July 23, 2024. This trademark is owned by MERCK KGAA. The LUVERIS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in the treatment of infertility
luveris

General Information

Serial Number97232962
Word MarkLUVERIS
Filing DateFriday, January 21, 2022
Status732 - THIRD EXTENSION - GRANTED
Status DateTuesday, July 23, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 20, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations for use in the treatment of infertility

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, January 26, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMERCK KGAA
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDarmstadt 64293
DE
Party NameMERCK KGAA
Party Type10 - Original Applicant
Legal Entity Type99 - Other
Address64293 Darmstadt F128/002
DE

Trademark Events

Event DateEvent Description
Tuesday, January 25, 2022NEW APPLICATION ENTERED
Wednesday, January 26, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 12, 2022ASSIGNED TO EXAMINER
Tuesday, July 12, 2022NON-FINAL ACTION WRITTEN
Tuesday, July 12, 2022NON-FINAL ACTION E-MAILED
Tuesday, July 12, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, November 10, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, November 10, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, November 10, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, November 14, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 30, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 20, 2022PUBLISHED FOR OPPOSITION
Tuesday, December 20, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 14, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 13, 2024SOU EXTENSION 2 FILED
Thursday, August 3, 2023SOU TEAS EXTENSION RECEIVED
Thursday, August 3, 2023SOU EXTENSION 1 FILED
Thursday, August 3, 2023SOU EXTENSION 1 GRANTED
Saturday, August 5, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 13, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, February 13, 2024SOU EXTENSION 2 GRANTED
Wednesday, February 14, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 23, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, July 23, 2024SOU EXTENSION 3 GRANTED
Tuesday, July 23, 2024SOU EXTENSION 3 FILED
Wednesday, July 24, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

luveris infertility treatment preparations pharmaceutical